z-logo
open-access-imgOpen Access
Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
Author(s) -
Garrido Paniagua Sara,
Prieto Martínez Pablo,
Cachón Rafael Forés,
Bautista Carrascosa Guiomar,
Duarte Rafael F.,
Krsnik Isabel
Publication year - 2021
Publication title -
ejhaem
Language(s) - English
Resource type - Journals
ISSN - 2688-6146
DOI - 10.1002/jha2.205
Subject(s) - medicine , multiple myeloma , thalidomide , autologous stem cell transplantation , bortezomib , lenalidomide , bone marrow , immunology , gastroenterology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom